by Dolly the Sheep | Apr 9, 2024 | Cancer, Immunology
FLYER ON CANCER IMMUNE CHECKPOINT GENETEX: CANCER IMMUNE CHECKPOINT ANTIBODIES Increasing knowledge of how cancer cells escape immune destruction has significantly driven the evolution of cancer immunotherapy. In particular, studies describing how different immune...
by Dolly the Sheep | Apr 9, 2024 | Cancer, Immunology
POSTERS ON CANCER SIGNALING POSTERS DOWNLOAD: CANCER SIGNALING Cancer-causing mutations impact signaling pathways and affecting apoptosis, autophagy, cell migration, angiogenesis and cell division cycle. GeneTex released a poster highlighting selected cancer signaling...
by Dolly the Sheep | Mar 26, 2024 | Cancer, Immunology, in vivo Studies, Neurology
FEATURED PRODUCTS FROM BIO X CELL Bio X Cell Biosimilar Research Grade Antibodies Research-Grade Biosimilar Monoclonal Antibodies InVivoSIM™ are research-grade biosimilar monoclonal antibodies that have the same active biological component as the original therapeutic...
by Dolly the Sheep | Mar 26, 2024 | Cancer, Immunology, in vivo Studies, Neurology
FEATURED PRODUCTS FROM BIO X CELL Bio X Cell Recombinant antibodies for in-vivo use RecombiMAb™ Primary Antibodies RecombiMAb™ antibodies use mouse or human IgG constant regions instead of the typical rat or hamster IgG constant regions, resulting in improved in vivo...
by Dolly the Sheep | Mar 26, 2024 | Cancer, Immunology, in vivo Studies, Neurology
ARTICLE FROM BIO X CELL FcgRs Modulate the Anti-tumor Activity of anti-PD-1/PD-L1 Antibodies Bio X Cell has recently published a scientific article featuring a journal publication that highlights the value of considering Fc domain interactions in research and...